5402222025-01-012025-03-315402222025-03-315402222024-03-315402222024-04-012025-03-315402222025-01-012025-03-31in-capmkt:OtherExpenses1Member5402222024-04-012025-03-31in-capmkt:OtherExpenses1Member5402222025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15402222025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25402222024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15402222024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25402222025-01-012025-03-31RelatedPartyTransactionDomain15402222024-12-31RelatedPartyTransactionDomain15402222025-03-31RelatedPartyTransactionDomain15402222025-01-012025-03-31RelatedPartyTransactionDomain25402222024-12-31RelatedPartyTransactionDomain25402222025-03-31RelatedPartyTransactionDomain25402222025-01-012025-03-31RelatedPartyTransactionDomain35402222024-12-31RelatedPartyTransactionDomain35402222025-03-31RelatedPartyTransactionDomain35402222025-01-012025-03-31RelatedPartyTransactionDomain45402222024-12-31RelatedPartyTransactionDomain45402222025-03-31RelatedPartyTransactionDomain45402222025-01-012025-03-31RelatedPartyTransactionDomain55402222024-12-31RelatedPartyTransactionDomain55402222025-03-31RelatedPartyTransactionDomain55402222025-01-012025-03-31RelatedPartyTransactionDomain65402222024-12-31RelatedPartyTransactionDomain65402222025-03-31RelatedPartyTransactionDomain65402222025-01-012025-03-31RelatedPartyTransactionDomain75402222024-12-31RelatedPartyTransactionDomain75402222025-03-31RelatedPartyTransactionDomain75402222025-01-012025-03-31RelatedPartyTransactionDomain85402222024-12-31RelatedPartyTransactionDomain85402222025-03-31RelatedPartyTransactionDomain85402222025-01-012025-03-31RelatedPartyTransactionDomain95402222024-12-31RelatedPartyTransactionDomain95402222025-03-31RelatedPartyTransactionDomain95402222025-01-012025-03-31RelatedPartyTransactionDomain105402222024-12-31RelatedPartyTransactionDomain105402222025-03-31RelatedPartyTransactionDomain105402222025-01-012025-03-31RelatedPartyTransactionDomain115402222024-12-31RelatedPartyTransactionDomain115402222025-03-31RelatedPartyTransactionDomain115402222025-01-012025-03-31RelatedPartyTransactionDomain125402222024-12-31RelatedPartyTransactionDomain125402222025-03-31RelatedPartyTransactionDomain125402222025-01-012025-03-31RelatedPartyTransactionDomain135402222024-12-31RelatedPartyTransactionDomain135402222025-03-31RelatedPartyTransactionDomain135402222025-01-012025-03-31RelatedPartyTransactionDomain145402222024-12-31RelatedPartyTransactionDomain145402222025-03-31RelatedPartyTransactionDomain145402222025-01-012025-03-31RelatedPartyTransactionDomain155402222024-12-31RelatedPartyTransactionDomain155402222025-03-31RelatedPartyTransactionDomain155402222025-01-012025-03-31RelatedPartyTransactionDomain165402222024-12-31RelatedPartyTransactionDomain165402222025-03-31RelatedPartyTransactionDomain165402222025-01-012025-03-31RelatedPartyTransactionDomain175402222024-12-31RelatedPartyTransactionDomain175402222025-03-31RelatedPartyTransactionDomain175402222025-01-012025-03-31RelatedPartyTransactionDomain185402222024-12-31RelatedPartyTransactionDomain185402222025-03-31RelatedPartyTransactionDomain185402222025-01-012025-03-31RelatedPartyTransactionDomain195402222024-12-31RelatedPartyTransactionDomain195402222025-03-31RelatedPartyTransactionDomain195402222025-01-012025-03-31RelatedPartyTransactionDomain205402222024-12-31RelatedPartyTransactionDomain205402222025-03-31RelatedPartyTransactionDomain205402222025-01-012025-03-31RelatedPartyTransactionDomain215402222024-12-31RelatedPartyTransactionDomain215402222025-03-31RelatedPartyTransactionDomain215402222025-01-012025-03-31RelatedPartyTransactionDomain225402222024-12-31RelatedPartyTransactionDomain225402222025-03-31RelatedPartyTransactionDomain225402222025-01-012025-03-31RelatedPartyTransactionDomain235402222024-12-31RelatedPartyTransactionDomain235402222025-03-31RelatedPartyTransactionDomain235402222025-01-012025-03-31RelatedPartyTransactionDomain245402222024-12-31RelatedPartyTransactionDomain245402222025-03-31RelatedPartyTransactionDomain245402222025-01-012025-03-31RelatedPartyTransactionDomain255402222024-12-31RelatedPartyTransactionDomain255402222025-03-31RelatedPartyTransactionDomain255402222025-01-012025-03-31RelatedPartyTransactionDomain265402222024-12-31RelatedPartyTransactionDomain265402222025-03-31RelatedPartyTransactionDomain265402222025-01-012025-03-31RelatedPartyTransactionDomain275402222024-12-31RelatedPartyTransactionDomain275402222025-03-31RelatedPartyTransactionDomain275402222025-01-012025-03-31RelatedPartyTransactionDomain285402222024-12-31RelatedPartyTransactionDomain285402222025-03-31RelatedPartyTransactionDomain285402222025-01-012025-03-31RelatedPartyTransactionDomain295402222024-12-31RelatedPartyTransactionDomain295402222025-03-31RelatedPartyTransactionDomain295402222025-01-012025-03-31RelatedPartyTransactionDomain305402222024-12-31RelatedPartyTransactionDomain305402222025-03-31RelatedPartyTransactionDomain305402222025-01-012025-03-31RelatedPartyTransactionDomain315402222024-12-31RelatedPartyTransactionDomain315402222025-03-31RelatedPartyTransactionDomain315402222025-01-012025-03-31RelatedPartyTransactionDomain325402222024-12-31RelatedPartyTransactionDomain325402222025-03-31RelatedPartyTransactionDomain325402222025-01-012025-03-31RelatedPartyTransactionDomain335402222024-12-31RelatedPartyTransactionDomain335402222025-03-31RelatedPartyTransactionDomain335402222025-01-012025-03-31RelatedPartyTransactionDomain345402222024-12-31RelatedPartyTransactionDomain345402222025-03-31RelatedPartyTransactionDomain345402222025-01-012025-03-31RelatedPartyTransactionDomain355402222024-12-31RelatedPartyTransactionDomain355402222025-03-31RelatedPartyTransactionDomain355402222025-01-012025-03-31RelatedPartyTransactionDomain365402222024-12-31RelatedPartyTransactionDomain365402222025-03-31RelatedPartyTransactionDomain365402222025-01-012025-03-31RelatedPartyTransactionDomain375402222024-12-31RelatedPartyTransactionDomain375402222025-03-31RelatedPartyTransactionDomain375402222025-01-012025-03-31RelatedPartyTransactionDomain385402222024-12-31RelatedPartyTransactionDomain385402222025-03-31RelatedPartyTransactionDomain385402222025-01-012025-03-31RelatedPartyTransactionDomain395402222024-12-31RelatedPartyTransactionDomain395402222025-03-31RelatedPartyTransactionDomain395402222025-01-012025-03-31RelatedPartyTransactionDomain405402222024-12-31RelatedPartyTransactionDomain405402222025-03-31RelatedPartyTransactionDomain405402222025-01-012025-03-31RelatedPartyTransactionDomain415402222024-12-31RelatedPartyTransactionDomain415402222025-03-31RelatedPartyTransactionDomain415402222025-01-012025-03-31RelatedPartyTransactionDomain425402222024-12-31RelatedPartyTransactionDomain425402222025-03-31RelatedPartyTransactionDomain425402222025-01-012025-03-31RelatedPartyTransactionDomain435402222024-12-31RelatedPartyTransactionDomain435402222025-03-31RelatedPartyTransactionDomain435402222025-01-012025-03-31RelatedPartyTransactionDomain445402222024-12-31RelatedPartyTransactionDomain445402222025-03-31RelatedPartyTransactionDomain445402222025-01-012025-03-31RelatedPartyTransactionDomain455402222024-12-31RelatedPartyTransactionDomain455402222025-03-31RelatedPartyTransactionDomain455402222025-01-012025-03-31RelatedPartyTransactionDomain465402222024-12-31RelatedPartyTransactionDomain465402222025-03-31RelatedPartyTransactionDomain465402222025-01-012025-03-31RelatedPartyTransactionDomain475402222024-12-31RelatedPartyTransactionDomain475402222025-03-31RelatedPartyTransactionDomain475402222025-01-012025-03-31RelatedPartyTransactionDomain485402222024-12-31RelatedPartyTransactionDomain485402222025-03-31RelatedPartyTransactionDomain485402222025-01-012025-03-31RelatedPartyTransactionDomain495402222024-12-31RelatedPartyTransactionDomain495402222025-03-31RelatedPartyTransactionDomain495402222025-01-012025-03-31RelatedPartyTransactionDomain505402222024-12-31RelatedPartyTransactionDomain505402222025-03-31RelatedPartyTransactionDomain505402222025-01-012025-03-31RelatedPartyTransactionDomain515402222024-12-31RelatedPartyTransactionDomain515402222025-03-31RelatedPartyTransactionDomain515402222025-01-012025-03-31RelatedPartyTransactionDomain525402222024-12-31RelatedPartyTransactionDomain525402222025-03-31RelatedPartyTransactionDomain525402222025-01-012025-03-31RelatedPartyTransactionDomain535402222024-12-31RelatedPartyTransactionDomain535402222025-03-31RelatedPartyTransactionDomain535402222025-01-012025-03-31RelatedPartyTransactionDomain545402222024-12-31RelatedPartyTransactionDomain545402222025-03-31RelatedPartyTransactionDomain545402222025-01-012025-03-31RelatedPartyTransactionDomain555402222024-12-31RelatedPartyTransactionDomain555402222025-03-31RelatedPartyTransactionDomain555402222025-01-012025-03-31RelatedPartyTransactionDomain565402222024-12-31RelatedPartyTransactionDomain565402222025-03-31RelatedPartyTransactionDomain565402222025-01-012025-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares540222LAURUSLABSNOTLISTEDINE947Q01028LAURUS LABS LIMITEDMain BoardEquity2024-04-012025-03-312025-04-242025-04-10INRCroresQuarterlyFourth quarterSingle segmentManufacturer of Generics API, Generics FDF, Synthesis and Bio Technology2025-04-2414:00:002025-04-2414:45:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-04-24www.lauruslabs.comfalsefalseNA2025-01-012025-03-31UnauditedStandalone1650010000072160000017221700000604440000022310000015470000001487700000486000000881900000324960000013919700000330200000003302000000820700000-377000007830000000251900000000002519000000-161000002502900000107850000024.684.67004.684.670001. The above standalone financial results of Laurus Labs Limited has been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on April 24, 2025. The results for the year ended March 31, 2025 has been audited and for the quarter ended March 31, 2025 has been reviewed by our statutory auditors. The statutory auditors of the Company have expressed an unmodified opinion on the financial results for the year ended March 31, 2025 and have issued an unmodified conclusion in respect of the limited review for the quarter ended March 31, 2025. <BR> 2. These standalone financial results of the Company have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India. <BR> 3. The Company is engaged in the manufacture and sale of Pharmaceuticals which constitutes a single reportable business segment as per Ind AS 108 Operating Segments. <BR> 4. During the year ended March 31, 2025, the Company allotted 286,633 equity shares of Rs.2 each, consequent to the exercise of the stock options by the employees of the Company under the Employee Stock Option Scheme. <BR> 5. The Board of Directors, at their meeting held on April 24, 2025 approved for the payment of interim dividend of Rs.0.80 per equity share of Rs.2 each. <BR> 6. During the quarter ended March 31, 2025, the Company sold its land situated at MN Park, Hyderabad, Telangana at fair value to KRKA Pharma Private Limited and recognised the profit of Rs.58.85 crores, which was classified as Other Income. <BR> 7. The figures for the current quarter and quarter ended March 31, 2024 are the balancing figures between the audited figures in respect of the full financial year ended March 31, 2025 and March 31, 2024, respectively and published year to date figures up to third quarter ended December 31, 2024 and December 31, 2023, respectively, which are subject to limited review by the statutory auditors.2024-04-012025-03-31AuditedStandalone52169800000100470000053174500000237138000001053600000-13550000060864000001822000000358790000012008200000481364000005038100000050381000001538400000-30420000012342000000380390000000003803900000-7600000379630000010785000002445610000007.067.05007.067.05000Other Expenses3249600000Other Expenses120082000002762970000033624000000017630000000074022000000466500000015091000001357630000001055000000457997000001738880000002035070000050360000028000006690000012930000021053300000016257000004006780000000858675000001078500000445610000004563950000045639500000414250000000046900000046115000009672000003563000000267260000086076000001910390000024460000090424000009287000000202230000030413200000396300000276300000534600000031620400000004022800000085867500000-353700000-417300000-4472900000000-37520000000-654000000000358790000000026395000000100000001023000000000-5812000000-52450000045136000000-1773000000013439000004579000005400600000000001053500000009900000003806800000000000000000033900000009900000000003537000000100000-591650000000000010170000005246500000244420000011810000043130000017614000000059320000077300000077300000426300000503600000(i) Remeasurement gains/(losses) on defined benefit plans-21600000ii) Income tax relating to items that will not be reclassified to profit or loss in subsequent periods5500000-16100000(i) Remeasurement gains/(losses) on defined benefit plans-10200000ii) Income tax relating to items that will not be reclassified to profit or loss in subsequent periods2600000-76000000000-16100000-7600000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanyAny other transactionConversion ChargesApproved4110000000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanyPurchase of goods or servicesApproved13440000000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanySale of goods or servicesApproved1250000000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanyAny other transactionCorporate Support service chargesApproved310000000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanySale of fixed assetsApproved70000000Laurus Labs Limited******Sriam Labs Private Limited******Subsidiary CompanyAny other transactionReimbursement of expensesApproved320000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyLoanApproved193000000029250000004405000000Loan0.085Repayable on demand as mutually agreedUnsecuredBusiness PurposeLaurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyAny other transactionLoan RepaidApproved45000000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyInterest receivedApproved17210000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyAny other transactionConversion ChargesApproved1700000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyPurchase of goods or servicesApproved42840000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanySale of goods or servicesApproved6880000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanySale of fixed assetsApproved6420000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyPurchase of fixed assetsApproved70000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyAny other transactionConversion IncomeApproved26400000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyAny other transactionCorporate Support service IncomeApproved2380000000Laurus Labs Limited******Laurus Synthesis Private Limited******Subsidiary CompanyAny other transactionReimbursement of expensesApproved1060000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyLoanApproved20000000310000000320000000Loan0.085Repayable on demand as mutually agreedUnsecuredBusiness PurposeLaurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyAny other transactionLoan repaidApproved1000000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyInterest receivedApproved2260000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyAny other transactionProduct development expensesApproved8710000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyAny other transactionCorporate Support service IncomeApproved640000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanyPurchase of goods or servicesApproved610000000Laurus Labs Limited******Laurus Bio Private Limited******Subsidiary CompanySale of goods or servicesApproved70000000Laurus Labs Limited******Laurus Holdings Limited******Subsidiary CompanyAny other transactionBusiness promotion expensesApproved2370000000Laurus Labs Limited******Laurus Holdings Limited******Subsidiary CompanyAny other transactionCorporate Support service incomeApproved30000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companySale of goods or servicesApproved102290000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companyAny other transactionBusiness promotion expensesApproved14470000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companyAny other transactionCorporate Support service incomeApproved70000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companyAny other transactionConversion IncomeApproved2460000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companyAny other transactionInterest on corporate guaranteeApproved320000000Laurus Labs Limited******Laurus Generics Inc******Step down subsidiary companyPurchase of fixed assetsApproved140000000Laurus Labs Limited******Laurus Generics GmbH******Step down subsidiary companyAny other transactionCorporate Support service incomeApproved110000000Laurus Labs Limited******Ethan Energy India Private Limited******Associate CompanyPurchase of goods or servicesApproved3180000000Laurus Labs Limited******Chemiasoft Private Limited******Enterprise over which Key Management Personnel exercise significant influencePurchase of goods or servicesApproved1170000000Laurus Labs Limited******Laurus Charitable Trust******Enterprise over which Key Management Personnel exercise significant influenceAny other transactionDonations /CSR ExpenditureApproved13160000000Laurus Labs Limited******NSN Investments******Enterprise over which Key Management Personnel exercise significant influenceAny other transactionLease rental expensesApproved4920000000Laurus Labs Limited******NSN Investments******Enterprise over which Key Management Personnel exercise significant influenceAny other transactionReimbursement of expensesApproved410000000Laurus Labs Limited******KRKA Pharma Private Limited******Joint Venture CompanyInvestmentApproved105350000000Laurus Labs Limited******KRKA Pharma Private Limited******Joint Venture CompanySale of fixed assetsApproved90650000000Laurus Labs Limited******Dr. C. Satyanarayana******Key Management PersonnelRemunerationApproved16460000000Laurus Labs Limited******Mr. V.V. Ravi Kumar******Key Management PersonnelRemunerationApproved3880000000Laurus Labs Limited******Dr. C.V.Lakshmana Rao******Key Management PersonnelRemunerationApproved2580000000Laurus Labs Limited******Mr. G.Venkateswar Reddy******Key Management PersonnelRemunerationApproved400000000Laurus Labs Limited******Mr. C. Narasimha Rao******Promoter GroupRemunerationApproved730000000Laurus Labs Limited******Mr. C. Krishna Chaitanya******Key Management PersonnelRemunerationApproved1090000000Laurus Labs Limited******Mrs. C. Soumya******Key Management PersonnelRemunerationApproved710000000Sriam Labs Private Limited******Laurus Synthesis Private Limited******Subsidiaries of Laurus Labs LimitedAny other transactionInterest on inter corporate loanApproved1230000000Sriam Labs Private Limited******Laurus Synthesis Private Limited******Subsidiaries of Laurus Labs LimitedAny other transactionInter corporate loan givenApproved20000000275000000290000000Loan0.085Repayable on demand as mutually agreedUnsecuredBusiness PurposeSriam Labs Private Limited******Laurus Synthesis Private Limited******Subsidiaries of Laurus Labs LimitedAny other transactionInter corporate loan repaidApproved500000000Sriam Labs Private Limited******Laurus Synthesis Private Limited******Subsidiaries of Laurus Labs LimitedPurchase of goods or servicesApproved130000000Laurus Labs Limited******Dr. C. Satyanarayana on behalf of M/S. NSN Holdings******PromoterDividend paidApproved4970000000Laurus Labs Limited******Mr. V.V. Ravi Kumar******Key Management PersonnelDividend paidApproved40000000Laurus Labs Limited******Mr. V.V. Ravi Kumar on behalf of M/s. Leven Holdings******PromoterDividend paidApproved270000000Laurus Labs Limited******Dr. C.V.Lakshmana Rao******Key Management PersonnelDividend paidApproved540000000Laurus Labs Limited******Donald H Rolfe******Significant Beneficial OwnerDividend paidApproved24000000007567800000AuditedtrueDeloitte Haskins and Sells LLPtrue2027-07-31